A comparative study of efficacy and safety of glucosamine plus chondroitin sulphate versus rosehip as add on therapy to NSAIDs in patients suffering from osteoarthritis
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20184336Keywords:
Glucosamine and chondroitin sulphate, Osteoarthritis, RosehipAbstract
Background: Osteoarthritis is a chronic and debilitating disease. Management of disease is a big challenge. NSAIDS play an important role but have many adverse reactions. So, this study was designed to evaluate the efficacy and safety of natural compound rosehip versus glucosamine and chondroitin sulphate in patients of osteoarthritis.
Methods: An open label, randomized, parallel group comparative study, conducted on patients of either sex with confirmed diagnosis of osteoarthritis on standard NSAIDs therapy, attending the outpatient department of orthopedics in a tertiary care centre. 150 patients were enrolled and divided into three groups (group A, group B and group C) of 50 each. Patients of group A were given Glucosamine plus chondroitin sulphate for 12 weeks. Group B was given rosehip for 12 weeks and group C placebo. These supplements were given as add on therapy. Patients were monitored and adverse drug reactions were noted. The data was analysed statistically using t- test for efficacy and descriptive stats for assessing the safety.
Results: Efficacy was assessed by comparing mean reduction in the pain intensity between group A and B, group B gives highly significant results as compared to group A. While comparing joint tenderness, swelling around joint, mean functional capacity and improvement in the overall assessment, group B gives significant results as compared to group A. It was also observed that group A and group B were better than group C in all the efficacy parameters. All the drugs were well tolerated and systemically safe.
Conclusions: There was significant difference in efficacy of rosehip compared with glaucosamine and chondroitin sulphate in patients of osteoarthritis. In comparison there was no significant difference in safety of two drugs and both were considered safe in patients.
References
Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organization. 2003;81:646-56.
Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005 Mar 12;365(9463):965-73.
Brandt KD. Osteoarthritis In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison’s Principles of Internal Medicine. 16th ed. Newyork, NY:Mcgraw-Hill companies; 2005:2037.
Lippiello L. Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthr Cartilage. 2003 May 1;11(5):335-42.
Christensen LP. Galactolipids as potential health promoting compounds in vegetable foods. Recent Patents Food Nutr Agricult. 2009 Jan 1;1(1):50-8.
Wenzig EM, Widowitz U, Kunert O, Chrubasik S, Bucar F, Knauder E, et al. Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations. Phytomedicine. 2008 Oct 17;15(10):826-35.
Spilker B. Drug development and approval process. In: Speight TM, Holford NHG, eds. Avery’s Drug Treatment. 4th ed. Auckland Adis International; 1997:423-449.
Allen IE, Seaman CA. Likert scales and data analyses. Quality Progress. 2007 Jul 1;40(7):64-5.
Crossland J. Statistics in pharmacology. In: Lewis’s pharmacology. 5th ed. Edinburg: Churchill Livingstone; 1982:112-114.
Clegg DO, Reda DJ, Harris CL, Klein MA, O'dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Eng J Med. 2006 Feb 23;354(8):795-808.
Schwager J, Hoeller U, Wolfram S, Richard N. Rose hip and its constituent galactolipids confer cartilage protection by modulating cytokine, and chemokine expression. BMC Complement Altern Med. 2011 Dec;11(1):105.
Christensen R, Bartels EM, Bliddal H. 521 Efficacy of glucosamine hydrochloride or specialized rosehip powder in osteoarthritis patients: an indirect comparison meta-analysis. Osteoarthritis Cartilage. 2009 Sep 1;17:S279.
Warholm O, Skaar S, Hedman E, Mølmen HM, Eik L. The effects of a standardized herbal remedy made from a subtype of Rosa canina in patients with osteoarthritis: a double-blind, randomized, placebo-controlled clinical trial. Cur Therap Res. 2003 Jan 1;64(1):21-31.
Chan PS, Caron JP, Rosa GJ, Orth MW. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants. Osteoarthritis Cartilage. 2005 May 1;13(5):387-94.
Winther K, Apel K, Thamsborg G. A powder made from seeds and shells of a rose‐hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double‐blind, placebo‐controlled clinical trial. Scand J Rheumatol. 2005 Jan 1;34(4):302-8.
Rein E, Kharazmi A, Winther K. A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis:a double-blind, placebo-controlled, randomised trial. Phytomedicine. 2004 Jul 20;11(5):383-91.
Yang S, Eaton CB, McAlindon TE, Lapane KL. Effects of glucosamine and chondroitin on treating knee osteoarthritis: An analysis with marginal structural models. Arthritis Rheumatol. 2015 Mar;67(3):714-23.
Chrubasik S, Chrubasik C, Neumann E, Müller-Ladner U. For anti-inflammatory efficacy of rosehip powder. J Phytotherapy. 2009 Oct;30(05):227-31.
